Literature DB >> 20163386

Conducting clinical research with prescription opioid dependence: defining the population.

Roger D Weiss1, Jennifer S Potter, Marc L Copersino, Kristi Prather, Petra Jacobs, Scott Provost, David Chim, Jeffrey Selzer, Walter Ling.   

Abstract

Most treatment studies of opioid-dependent populations have focused predominantly on heroin users, despite a recent increase in those dependent upon prescription opioids. A key methodological challenge involved in studying the latter group involves defining the population. Specifically, researchers must decide whether to include (1) concurrent heroin users and (2) individuals with pain. The multi-site Prescription Opioid Addiction Treatment Study is examining treatments for this population. This paper describes various inclusion criteria considered by the study team related to heroin use and pain. The goal was to recruit a distinct but generalizable population of individuals dependent upon prescription opioids. (Am J Addict 2010;00:1-6).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163386      PMCID: PMC2852106          DOI: 10.1111/j.1521-0391.2009.00017.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  16 in total

1.  Prescription opioid abuse in patients presenting for methadone maintenance treatment.

Authors:  Bruna Brands; Joan Blake; Beth Sproule; Douglas Gourlay; Usoa Busto
Journal:  Drug Alcohol Depend       Date:  2004-02-07       Impact factor: 4.492

Review 2.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; John T Farrar; Jennifer A Haythornthwaite; Mark P Jensen; Nathaniel P Katz; Robert D Kerns; Gerold Stucki; Robert R Allen; Nicholas Bellamy; Daniel B Carr; Julie Chandler; Penney Cowan; Raymond Dionne; Bradley S Galer; Sharon Hertz; Alejandro R Jadad; Lynn D Kramer; Donald C Manning; Susan Martin; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; Wendye Robbins; James P Robinson; Margaret Rothman; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; Joachim Wernicke; James Witter
Journal:  Pain       Date:  2005-01       Impact factor: 6.961

3.  Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.

Authors:  Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Veronica M Frajzyngier; Samuel R Friedman; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

4.  Characterizing the emerging population of prescription opioid abusers.

Authors:  Stacey C Sigmon
Journal:  Am J Addict       Date:  2006 May-Jun

5.  High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study.

Authors:  Crystal M Fuller; David Vlahov; Danielle C Ompad; Nina Shah; Amelia Arria; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2002-04-01       Impact factor: 4.492

6.  Substance use histories in patients seeking treatment for controlled-release oxycodone dependence.

Authors:  Jennifer Sharpe Potter; Grace Hennessy; Jennifer A Borrow; Shelly F Greenfield; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2004-11-11       Impact factor: 4.492

7.  A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

Authors:  P G O'Connor; A H Oliveto; J M Shi; E G Triffleman; K M Carroll; T R Kosten; B J Rounsaville; J A Pakes; R S Schottenfeld
Journal:  Am J Med       Date:  1998-08       Impact factor: 4.965

Review 8.  Clinical efficacy of buprenorphine: comparisons to methadone and placebo.

Authors:  Walter Ling; Donald R Wesson
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

Review 9.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

10.  Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.

Authors:  Geetha A Subramaniam; Maxine A Stitzer
Journal:  Drug Alcohol Depend       Date:  2008-12-09       Impact factor: 4.492

View more
  13 in total

1.  Comparing buprenorphine induction experience with heroin and prescription opioid users.

Authors:  Suzanne Nielsen; Maureen Hillhouse; Larissa Mooney; Jacqueline Fahey; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2012-02-01

2.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

3.  Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.

Authors:  Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Robert N Jamison; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2016-04-25       Impact factor: 4.492

4.  Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; Scott E Provost; Garrett M Fitzmaurice; Katherine A McDermott; Emily N Srisarajivakul; Dorian R Dodd; Jessica A Dreifuss; R Kathryn McHugh; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2015-03-06       Impact factor: 4.492

5.  The multi-site prescription opioid addiction treatment study: 18-month outcomes.

Authors:  Jennifer Sharpe Potter; Jessica A Dreifuss; Elise N Marino; Scott E Provost; Dorian R Dodd; Lindsay S Rice; Garrett M Fitzmaurice; Margaret L Griffin; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-08-02

6.  From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Authors:  Walter Ling; Petra Jacobs; Maureen Hillhouse; Albert Hasson; Christie Thomas; Thomas Freese; Steven Sparenborg; Dennis McCarty; Roger Weiss; Andrew Saxon; Allan Cohen; Michele Straus; Gregory Brigham; David Liu; Paul McLaughlin; Betty Tai
Journal:  J Subst Abuse Treat       Date:  2010-06

7.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

8.  Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Authors:  Jessica A Dreifuss; Margaret L Griffin; Katherine Frost; Garrett M Fitzmaurice; Jennifer Sharpe Potter; David A Fiellin; Jeffrey Selzer; Mary Hatch-Maillette; Susan C Sonne; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

9.  A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview.

Authors:  Jennifer S Potter; Kristi Prather; Frankie Kropp; Mimmie Byrne; C Rollynn Sullivan; Nadia Mohamedi; Marc L Copersino; Roger D Weiss
Journal:  Contemp Clin Trials       Date:  2010-01-14       Impact factor: 2.226

10.  Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence.

Authors:  Christina S Meade; Lisa A Bevilacqua; Elizabeth D Moore; Margaret L Griffin; John G Gardin; Jennifer S Potter; Mary Hatch-Maillette; Roger D Weiss
Journal:  Am J Addict       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.